Dialysable lymphocyte extract (DLyE) in infantile onset autism: a pilot study.
40 infantile autistic patients were studied. They ranged from 6 years to 15 years of age at entry. 22 were cases of classical infantile autism; whereas 18 lacked one or more clinical defects associated with infantile autism ("pseudo-autism"). Of the 22 with classic autism, 21 responded to transfer factor (TF) treatment by gaining at least 2 points in symptoms severity score average (SSSA); and 10 became normal in that they were main-streamed in school and clinical characteristics were fully normalized. Of the 18 remaining, 4 responded to TF, some to other therapies. After cessation of TF therapy, 5 in the autistic group and 3 of the pseudo-autistic group regressed, but they did not drop as low as baseline levels.
Fudenberg
H H
HH
Neurolmmuno Therapeutics Research Foundation Spartanburg, S.C., USA.
D000293:Adolescent; D000906:Antibodies / Q000032:analysis; D001321:Autistic Disorder / Q000276:immunology / Q000628:therapy*; D002457:Cell Extracts / Q000627:therapeutic use*; D002648:Child; D003956:Dialysis; D005500:Follow-Up Studies; D006801:Humans; D008214:Lymphocytes / Q000737:chemistry / Q000276:immunology*; D004676:Myelin Basic Protein / Q000276:immunology; D010865:Pilot Projects; D014165:Transfer Factor / Q000627:therapeutic use*
D000906:Antibodies; D002457:Cell Extracts; D004676:Myelin Basic Protein; D014165:Transfer Factor